Regulations.gov document
Draft Guidance; Notifying FDA of a Discontinuance or Interruption in Manufacturing of…
Other · FDA-2020-D-1057 · posted Feb 5, 2024
Key facts
| Document ID | FDA-2020-D-1057-0046 |
|---|---|
| Title | Draft Guidance; Notifying FDA of a Discontinuance or Interruption in Manufacturing of Finished Products or Active Pharmaceutical Ingredients Under Section 506C of the FD&C Act Guidance for Industry |
| Document type | Other |
| Subtype | Guidance |
| Agency | FDA |
| Docket | FDA-2020-D-1057 |
| Posted | Feb 5, 2024 |
| Comment period opens | Feb 5, 2024 |
At a glance
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: